Cytonics, an early-stage biopharmaceutical company developing therapies for osteoarthritis, today announced that the last patient has completed their last visit in the Company's first-in-human ...

This infographic highlights the key advantages of CHO cells and the technologies that are pushing the boundaries of cell ...

French precision fermentation startup Bon Vivant has rebranded to Verley and rolled out a range of functional animal-free ...

We may be overconsuming protein, but our appetite for the nutrient shows no signs of being satiated – and future food brands ...

In high-risk patients with pulmonary arterial hypertension, Merck ’s fusion protein therapeutic Winrevair reduced the ...

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

Aqemia announces it is broadening and accelerating its computational platform to target RNAs using its physics-enabled generative AI engine. Building on successes in epitranscriptomics, Aqemia aims to ...

Strong revenue performance, including approximately $1.9 million milestone and license revenue recognized in 2024 <li /> Up to $7.5 mil ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

SineuGene Therapeutics receives US FDA’s investigational new drug application clearance for SNUG01 to treat amyotrophic lateral sclerosis: Beijing Thursday, March 27, 2025, 15:0 ...

Indianapolis Zoo and Eli Lilly are part of a push to move medical industry away from using horseshoe crab blood and towards ...